ABSTRACT The purpose of this study is to evaluate the effectiveness of an efficacy-enhancing treatment modality and compare it to standard of care in the treatment of depression in breast cancer patient specifically focusing on time of diagnosis, end of treatment and at time of recurrence.
Women with breast cancer will suffer from depression and will often benefit from some extra emotional support. Shock, anxiety, sadness and depression are natural reactions to breast cancer. Even if there is a supportive network of family and friends, a need to discuss these feelings will arise. Counseling can be particularly helpful when breast cancer can disrupt relationships, sex life, or plans for childbearing. If patients are experiencing depression, they may improve more rapidly with the help of brief counseling and or an efficacy-enhancing modality given at the above intervals. This should improve patient recovery both emotionally and with the cancer itself as we will see later.
Depressive symptoms range from mild to severe, from normal states of sadness to clinical syndromes, such as an adjustment disorder with depressed mood or a major depression (Brandt 2002). While the psychological phenomenon is certainly not unique to women with breast cancer, this program will examine depression in the context of breast cancer. This research will help to determine the impact of early interventions at the time of diagnosis, at time of recurrence and at end of treatment care to help decrease the impact of depression and enhance survival and quality of life of women diagnosed with breast cancer Review of Literature Depression is a serious medical condition that affects thought, feelings, and ability to function in everyday life. Depression can occur at any age. National Institute of Mental Health-sponsored studies estimate that 6% of 9 to 17 year olds in the U.S. and almost 10% of American adults, or...
<_ .05 we can reject the null hypothesis which is an objective of this study.>